Skip to main content
Equibles

Albert Seymour, Ph.D.

CEO

Q32 Bio Inc. (QTTB)

Board Member

Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Albert Seymour, Ph.D.

Albert Seymour, Ph.D. is recorded as CEO and Board Member at Q32 Bio Inc. (QTTB). Q32 Bio Inc. reported in an 8-K filed November 16, 2023 that Albert Seymour, Ph.D. resigned as director, effective November 17, 2023. Q32 Bio Inc. reported in an 8-K filed November 16, 2023 that Albert Seymour, Ph.D. was terminated as President and Chief Executive Officer, effective November 17, 2023. Q32 Bio Inc. reported in an 8-K filed September 8, 2022 that Albert Seymour, Ph.D. was appointed Class II director, effective September 6, 2022. Equibles holds 4 filed executive changes naming Albert Seymour, Ph.D.; each is listed under recent activity with its source filing.

“In addition, on November 16, 2023, Dr. Seymour resigned from the Company's board of directors, effective as of November 17, 2023.”
Q32 Bio Inc. Form 8-K, filed November 16, 2023 · Read the filing
“On November 16, 2023, subject to the execution of the Merger Agreement, the Board terminated the employment of each of Albert Seymour, Ph.D. and W. Bradford Smith, effective as of November 17, 2023.”
Q32 Bio Inc. Form 8-K, filed November 16, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Q32 Bio Inc.

QTTB

Current role

CEO, Board Member

2022-04-21–present

Leadership on record at Q32 Bio Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.